Revolution Medicines, Inc. (RVMD)

Nasdaq · Healthcare · Biotechnology
$161.20+1.11%As of 2026-11-22 · USD
Last session low $160.22Last session high $169.51
52-week low $71.1552-week high $224.31
Market cap
$34.87B
Sector
Healthcare

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)37.0In the neutral range (30 to 70)
MACD (12, 26, 9)-8.28Below its signal line (-5.59); histogram -2.69
Bollinger %B (20, 2)11%Inside the bands (155.29 to 207.37)
SMA 20181.33Price is 11.1% below
SMA 50190.05Price is 15.2% below
SMA 200161.53Price is 0.2% below
ATR (20)5.71% of priceAverage true range per day
52-week position59%In the middle of the 71.15 to 224.31 range

About Revolution Medicines, Inc.

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

Insider filings, 90 daysNo purchases and 20 sales (about $55.4M).
Latest fiscal yearEnded 2023-12-31: revenue of $11.58M and an operating margin of -4207.1%.

More in Biotechnology